
Caixa Capital Risc is the venture capital arm of CriteriaCaixa, headquartered in Barcelona, Spain. It invests in innovative companies at early and growth stages, primarily in Spain and Portugal, across life sciences, digital technology, and industrial technology sectors.
Deal activity decreased year-over-year (1 deals in the last 12 months vs 2 prior). Average disclosed round size is $47.9M (across 8 rounds with reported amounts).
Portfolio
29
Fund Size
—
Top Stage
Unknown
Last 12 Mo
2
Team
AL
Ana Luiza
Managing Partner
PC
Pablo Cironi
Director of Life Science Investment Funds
SS
Sergio San Agustín
Investment Director
RJ
Roma Jelinskaite
Principal
SC
Salvatore Cappadona
Associate
XA
Xavier Alvarez
Portfolio Company Transformation & Value Creation
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
32 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series A | — | May 2026 | |
| Series A | $61M | Jan 2026 | |
| Seed | $20.2M | Dec 2024 | |
| Seed | $17.2M | Oct 2024 | |
| Unknown | $2.7M | Jan 2024 | |
| Seed | — | Sep 2023 | |
| Series A | — | Sep 2023 | |
| AAboleris Holdco | Series A | — | Sep 2023 |
| Unknown | $81M | Jan 2023 | |
| Seed | — | Jul 2022 | |
| Seed | — | Jun 2022 | |
| Series G | $191M | Jan 2021 | |
| Series D | — | Jun 2019 | |
| MMinoryx Therapeutics | Series B | — | Sep 2018 |
| IIproteos | Unknown | — | Oct 2016 |
| Series A | $3.3M | Aug 2016 | |
| Unknown | — | May 2013 | |
| Series A | $7.0M | Oct 2010 | |
| Series B | — | — | |
| Unknown | — | — | |
| Series A | — | — | |
| Series E | — | — | |
| Unknown | — | — | |
| SSanifit Therapeutics | Unknown | — | — |
| Unknown | — | — |
Page 1 of 2
Top Co-Investors
Columbus Venture Partners6 shared
Ysios Capital5 shared
Inveready4 shared
Criteria Venture Tech3 shared
Banco Sabadell3 shared
Armilar Venture Partners2 shared
Nauta Capital2 shared
Andera Partners2 shared
Roche Venture Fund2 shared
Fund+2 shared
Kurma Partners2 shared
Idinvest Partners2 shared
Insight Partners2 shared
Naver2 shared
Korelya Capital2 shared
4BIO Capital2 shared
British Business Bank2 shared
Abingworth LLP2 shared
LifeArc Ventures2 shared
GoHub Ventures2 shared
Last updated: 8 September 2026